Peptide Schedule
NA-Semax Amidate7 residuesMEHFPGPEach bubble = one amino acid. Size = residue mass. Color = chemical class.NA-Semax Amidate
Benefits
About NA-Semax Amidate
NA-Semax Amidate (N-Acetyl Semax Amidate) is a modified version of the Russian nootropic peptide Semax, engineered with two chemical changes that set it apart from the original. The N-terminal acetyl group and C-terminal amide cap protect the peptide from enzymatic breakdown by aminopeptidases and carboxypeptidases, giving it greater stability in brain tissue and a longer effective window compared to unmodified Semax. The core sequence — ACTH(4-10) with a PGP extension — is identical to standard Semax, so the underlying mechanism is the same: it binds to melanocortin receptors and upregulates BDNF (brain-derived neurotrophic factor) and NGF (nerve growth factor) in the hippocampus and basal forebrain. What the acetylation and amidation change is the pharmacokinetic profile. Preliminary data suggests NA-Semax Amidate resists degradation in brain tissue longer than standard Semax, which may translate to a more sustained neurotrophic effect per dose. Potency is estimated at 3-5x that of standard Semax. This is a practical concern — users who dose NA-Semax Amidate at the same microgram range as regular Semax often report overstimulation, anxiety, and irritability. Starting at 100mcg intranasally and titrating up is the standard approach. Beyond the neurotrophic effects, the peptide interacts with serotonergic, dopaminergic, and enkephalin signaling pathways, which may explain the reported improvements in mood and stress resilience alongside cognitive enhancement.
Who Should Consider NA-Semax Amidate
- Individuals seeking cognitive enhancement and improved focus
- Those wanting a more potent and stable alternative to standard Semax
- People interested in neuroprotection and BDNF upregulation
- Users with stress-related cognitive decline or brain fog
How NA-Semax Amidate Works
NA-Semax Amidate shares the same core mechanism as Semax — it is a synthetic analog of the ACTH(4-10) fragment extended with Pro-Gly-Pro. The peptide activates melanocortin receptors (MC3R and MC4R) in the brain without triggering adrenal cortisol release, distinguishing it from full-length ACTH. Its primary neurotrophic effect comes from upregulation of BDNF: a single application of Semax at 50mcg/kg produces a 1.4-fold increase in BDNF protein and a 3-fold increase in exon III BDNF mRNA in the hippocampus, along with a 1.6-fold increase in TrkB receptor phosphorylation. It also raises NGF levels in the basal forebrain. Beyond neurotrophins, the peptide modulates serotonergic, dopaminergic, and enkephalin (opioid) signaling systems. The N-acetyl and amide modifications do not change receptor binding but increase resistance to aminopeptidase and carboxypeptidase degradation, extending the duration of activity in neural tissue.
What to Expect
Initial effects noticeable within hours of first dose — improved mental clarity, focus, and verbal fluency. Some users report mild stimulation or slight headache as the body adjusts.
Cognitive effects become more consistent. Improved working memory, sustained attention, and motivation. Mood stabilization and reduced anxiety are commonly reported.
Peak benefits during the latter half of the cycle. BDNF elevation reaches steady state. Enhanced learning capacity and stress resilience. End of standard 2-week cycle.
Cognitive benefits often persist for 1-3 weeks after stopping, likely due to sustained BDNF and NGF levels. Effects gradually return to baseline.
Dosing Protocol
| Level | Dose / Injection | Frequency |
|---|---|---|
| Beginner | 100mcg | Daily |
| Moderate | 300mcg | Daily |
| Aggressive | 600mcg | Daily |
Note: Enhanced Semax with N-acetyl + C-terminal amide modifications. 3-5x more potent than standard Semax — reduce dose accordingly. Intranasal preferred. Cycle 10-20 days on, 10-20 days off.
How to Inject NA-Semax Amidate
Primarily administered intranasally using a calibrated spray device. Administer in the morning or early afternoon — late dosing may interfere with sleep due to stimulatory effects. Tilt head slightly forward, spray into one nostril while closing the other, and inhale gently. Wait 5 minutes between sprays if splitting dose across nostrils. Subcutaneous injection is an alternative but less common. Start at 100mcg/day and increase by 100mcg every 2-3 days to assess tolerance.
Cycling Protocol
Standard protocol is 10-20 days on, 10-20 days off. Cognitive benefits often persist during the off period due to sustained BDNF elevation. Some users run 30-day cycles with longer breaks.
Pharmacokinetics
Source: Estimated from Semax PK data; acetylation/amidation extend half-life vs parent compound (~2-3 min IV)
Loading the interactive decay curve.
Side Effects
Generally well-tolerated at appropriate doses. Overstimulation, anxiety, and irritability are the most common issues — almost always caused by dosing too high (treating it like standard Semax). Hair thinning has been reported at high doses but is rare and reversible. Nasal irritation possible with intranasal use.
Contraindications
- Pregnancy or planning to become pregnant
- Breastfeeding
- Known hypersensitivity to Semax or ACTH-derived peptides
- Active bleeding disorders (peptide may influence immune/vascular gene expression)
- History of severe anxiety disorders (may worsen at higher doses)
Drug Interactions
- MAO inhibitors — potential for excessive serotonergic/dopaminergic stimulation
- Stimulant medications (amphetamines, methylphenidate) — additive CNS stimulation, use caution
- Anticoagulants — Semax influences vascular gene expression; monitor if combining
- Thyroid hormones — melanocortin pathway interactions; monitor thyroid function
Storage & Stability
Molecular Profile
Related Peptides
References
- Semax, an analog of ACTH(4-10) with cognitive effects, regulates BDNF and trkB expression in the rat hippocampusPubMed 16996037
- Semax, an analogue of adrenocorticotropin (4-10), binds specifically and increases levels of brain-derived neurotrophic factor protein in rat basal forebrainPubMed 16635254
- The peptide semax affects the expression of genes related to the immune and vascular systems in rat brain focal ischemia: genome-wide transcriptional analysisPubMed 24661604
- Brain Protein Expression Profile Confirms the Protective Effect of the ACTH(4-7)PGP Peptide (Semax) in a Rat Model of Cerebral Ischemia-ReperfusionPubMed 34201112